3651 - 3660 of 8587 Results
Title
Year
-
OPENTitle: Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and frameworkJournal Name: Frontiers in Systems BiologyPublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fsysb.2024.1351555Best OA location URL: https://www.frontiersin.org/articles/10.3389/fsysb.2024.1351555/pdf?isPublishedV2=FalseCitation Count: 4
-
OPENTitle: Serotonin transporter density in isolated rapid eye movement sleep behavioral disorderJournal Name: Frontiers in SleepPublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/frsle.2023.1298854Best OA location URL: https://www.frontiersin.org/articles/10.3389/frsle.2023.1298854/pdf?isPublishedV2=FalseCitation Count: 0
-
OPENTitle: Semantic Integration of Multi-Modal Data and Derived Neuroimaging Results Using the Platform for Imaging in Precision Medicine (PRISM) in the Arkansas Imaging Enterprise System (ARIES)Journal Name: Frontiers in Artificial IntelligencePublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/frai.2021.649970Best OA location URL: https://www.frontiersin.org/articles/10.3389/frai.2021.649970/pdfCitation Count: 11
-
OPENTitle: Fusion of biomedical imaging studies for increased sample size and diversity: a case study of brain MRIJournal Name: Frontiers in RadiologyPublisher: Frontiers Media SAVol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fradi.2024.1283392Best OA location URL: https://www.frontiersin.org/articles/10.3389/fradi.2024.1283392/pdf?isPublishedV2=FalseCitation Count: 0
-
OPENTitle: SNPs in cytochromes P450 catalyzing cholesterol degradation in brain are associated with Parkinson’s diseaseJournal Name: Frontiers in PharmacologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fphar.2024.1477009Best OA location URL: http://doi.org/10.3389/fphar.2024.1477009Citation Count: 1
-
OPENTitle: Sex differences in the association between Body Mass Index and cognitive function in Parkinson disease: a cross-sectional studyJournal Name: Frontiers in NutritionPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnut.2024.1420225Best OA location URL: https://doi.org/10.3389/fnut.2024.1420225Citation Count: 1
-
OPENTitle: The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-025-03834-0Best OA location URL: https://www.nature.com/articles/s41591-025-03834-0.pdfCitation Count: 0
-
OPENTitle: Microglia ferroptosis is regulated by SEC24B and contributes to neurodegenerationJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 26Issue #: 1Start Page: 12End Page: 26Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-022-01221-3Best OA location URL: https://www.nature.com/articles/s41593-022-01221-3.pdfCitation Count: 242
-
OPENTitle: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-02886-yBest OA location URL: https://www.nature.com/articles/s41591-024-02886-y.pdfCitation Count: 48
-
OPENTitle: Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 12Start Page: 3669End Page: 3675Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03270-6Best OA location URL: https://www.nature.com/articles/s41591-024-03270-6.pdfCitation Count: 18